1
|
Mascolo E, Liguori F, Stufera Mecarelli L, Amoroso N, Merigliano C, Amadio S, Volonté C, Contestabile R, Tramonti A, Vernì F. Functional Inactivation of Drosophila GCK Orthologs Causes Genomic Instability and Oxidative Stress in a Fly Model of MODY-2. Int J Mol Sci 2021; 22:ijms22020918. [PMID: 33477627 PMCID: PMC7831483 DOI: 10.3390/ijms22020918] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/16/2020] [Revised: 01/13/2021] [Accepted: 01/14/2021] [Indexed: 12/13/2022] Open
Abstract
Maturity-onset diabetes of the young (MODY) type 2 is caused by heterozygous inactivating mutations in the gene encoding glucokinase (GCK), a pivotal enzyme for glucose homeostasis. In the pancreas GCK regulates insulin secretion, while in the liver it promotes glucose utilization and storage. We showed that silencing the DrosophilaGCK orthologs Hex-A and Hex-C results in a MODY-2-like hyperglycemia. Targeted knock-down revealed that Hex-A is expressed in insulin producing cells (IPCs) whereas Hex-C is specifically expressed in the fat body. We showed that Hex-A is essential for insulin secretion and it is required for Hex-C expression. Reduced levels of either Hex-A or Hex-C resulted in chromosome aberrations (CABs), together with an increased production of advanced glycation end-products (AGEs) and reactive oxygen species (ROS). This result suggests that CABs, in GCK depleted cells, are likely due to hyperglycemia, which produces oxidative stress through AGE metabolism. In agreement with this hypothesis, treating GCK-depleted larvae with the antioxidant vitamin B6 rescued CABs, whereas the treatment with a B6 inhibitor enhanced genomic instability. Although MODY-2 rarely produces complications, our data revealed the possibility that MODY-2 impacts genome integrity.
Collapse
Affiliation(s)
- Elisa Mascolo
- Department of Biology and Biotechnology “Charles Darwin”, Sapienza University, 00185 Rome, Italy; (E.M.); (L.S.M.); (N.A.); (C.M.)
| | - Francesco Liguori
- Preclinical Neuroscience, IRCCS Santa Lucia Foundation, 00143 Rome, Italy; (F.L.); (S.A.); (C.V.)
| | - Lorenzo Stufera Mecarelli
- Department of Biology and Biotechnology “Charles Darwin”, Sapienza University, 00185 Rome, Italy; (E.M.); (L.S.M.); (N.A.); (C.M.)
| | - Noemi Amoroso
- Department of Biology and Biotechnology “Charles Darwin”, Sapienza University, 00185 Rome, Italy; (E.M.); (L.S.M.); (N.A.); (C.M.)
| | - Chiara Merigliano
- Department of Biology and Biotechnology “Charles Darwin”, Sapienza University, 00185 Rome, Italy; (E.M.); (L.S.M.); (N.A.); (C.M.)
- Department of Molecular and Computational Biology, University of Southern California, Los Angeles, CA 90089, USA
| | - Susanna Amadio
- Preclinical Neuroscience, IRCCS Santa Lucia Foundation, 00143 Rome, Italy; (F.L.); (S.A.); (C.V.)
| | - Cinzia Volonté
- Preclinical Neuroscience, IRCCS Santa Lucia Foundation, 00143 Rome, Italy; (F.L.); (S.A.); (C.V.)
- Institute for Systems Analysis and Computer Science “A. Ruberti”, National Research Council (IASI-CNR), 00185 Rome, Italy
| | - Roberto Contestabile
- Istituto Pasteur Italia-Fondazione Cenci Bolognetti and Department of Biochemical Sciences “A. Rossi Fanelli”, Sapienza University, 00185 Rome, Italy; (R.C.); (A.T.)
| | - Angela Tramonti
- Istituto Pasteur Italia-Fondazione Cenci Bolognetti and Department of Biochemical Sciences “A. Rossi Fanelli”, Sapienza University, 00185 Rome, Italy; (R.C.); (A.T.)
- Istituto di Biologia e Patologia Molecolari, Consiglio Nazionale delle Ricerche, 00185 Rome, Italy
| | - Fiammetta Vernì
- Department of Biology and Biotechnology “Charles Darwin”, Sapienza University, 00185 Rome, Italy; (E.M.); (L.S.M.); (N.A.); (C.M.)
- Correspondence:
| |
Collapse
|